Literature DB >> 505092

Endocarditis caused by Moraxella nonliquefaciens.

D L Bechard, J L LeFrock, J R Tillotson.   

Abstract

We have described a case of endocarditis caused by Moraxella nonliquefaciens on a prosthetic Hancock valve, which was cured with a six-week course of ampicillin and gentamicin therapy. Cases of Moraxella septicemia or endocarditis are uncommon, and this apparently represents the first case of Moraxella nonliquefaciens endocarditis on a prosthetic valve. The fastidious growth characteristics of this and similar species may require prolonged incubation of blood cultures and development of different methods for testing the bactericidal activity of the patient's serum.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 505092     DOI: 10.1097/00007611-197911000-00045

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

1.  Infective endocarditis caused by Kingella kingae.

Authors:  R Adachi; O Hammerberg; H Richardson
Journal:  Can Med Assoc J       Date:  1983-05-01       Impact factor: 8.262

2.  Endocarditis due to Kingella kingae.

Authors:  L Odum; K T Jensen; T D Slotsbjerg
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

3.  Profiling bacterial community in upper respiratory tracts.

Authors:  Hana Yi; Dongeun Yong; Kyungwon Lee; Yong-Joon Cho; Jongsik Chun
Journal:  BMC Infect Dis       Date:  2014-11-13       Impact factor: 3.090

4.  A fatal endocarditis case due to an emerging bacterium: Moraxella nonliquefaciens.

Authors:  C Duployez; C Loïez; G Ledoux; S Armand; E Jaillette; F Wallet
Journal:  IDCases       Date:  2017-02-13

5.  Incidental diagnosis of sternoclavicular septic arthritis with Moraxella nonliquefaciens.

Authors:  Ehab Saad Aldin; Poorani Sekar; Zein Saad Eddin; Jaclyn Keller; Janet Pollard
Journal:  IDCases       Date:  2018-03-14

Review 6.  Infective Endocarditis by Moraxella Species: A Systematic Review.

Authors:  Petros Ioannou; Konstantinos Alexakis; Stella Baliou; Diamantis P Kofteridis
Journal:  J Clin Med       Date:  2022-03-27       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.